0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
1469 Views 
0 Saved
0 Vote 1 Contributor1469 Views 0 SavedYou might also be interested in
If you’re looking for a good oncologist in Hyderabad, some well-known names include Dr. Sumanth Kumar Mallupattu, Dr. Vishal Toka, and Dr. T Vishal. They are experienced in diagnosing and treating various types of cancers and are known for their patient-friendly approach. Many patients trust them fo....
You can get in touch with the following associations for financial help. Cancer Patients Aid Association King George V. Memorial, Smt. Panadevi Dalmia Cancer, Management Centre, Dr. E. Moses Road, Mahalaxmi, Mumbai 400 011, Maharashtra, India. Telephone: +91 22 24924000 or +91 22 24928775 ....
There are few things more alarming than battling cancer. One is not having the money for its treatment. Given the recent spike in incidence of cancer and its treatment costs, this could soon be a reality than mere speculation. At present breast cancer treatment in India costs almost 6 lakhs, while i....
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.